Andera Partners

Latest statistics and disclosures from Andera Partners's latest quarterly 13F-HR filing:

  • Top 5 stock holdings are KMTS, MLYS, Avalyn Pharma, AGMB, EVMN, and represent 87.88% of Andera Partners's stock portfolio.
  • Added to shares of these 3 stocks: Avalyn Pharma (+$31M), IVA (+$6.9M), KMTS.
  • Started 1 new stock position in Avalyn Pharma.
  • Reduced shares in these 1 stock: EVMN (-$6.7M).
  • Andera Partners was a net buyer of stock by $32M.
  • Andera Partners has $207M in assets under management (AUM), dropping by 16.71%.
  • Central Index Key (CIK): 0001757283

Tip: Access up to 7 years of quarterly data

Positions held by Andera Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Andera Partners

Andera Partners holds 8 positions in its portfolio as reported in the June 2026 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Kestra Med Technologies SHS (KMTS) 33.6 $69M 2.7M 25.44
 View chart
Mineralys Therapeutics (MLYS) 20.8 $43M 1.6M 26.98
 View chart
Avalyn Pharmaceuticals Com Shs 14.8 $31M NEW 930k 32.92
 View chart
Agomab Therapeutics Nv Sponsored Ads (AGMB) 9.7 $20M 1.5M 12.98
 View chart
Evommune Com Shs (EVMN) 9.0 $19M -26% 1.4M 13.29
 View chart
Inventiva Sa Ads (IVA) 6.7 $14M +99% 3.6M 3.78
 View chart
Abivax Sa Sponsored Ads (ABVX) 5.0 $10M 78k 133.26
 View chart
Nyxoah S A SHS (NYXH) 0.4 $882k 522k 1.69
 View chart

Past Filings by Andera Partners

SEC 13F filings are viewable for Andera Partners going back to 2026